What's New
-
2025-12-24
(24 December 2025, Hong Kong) In alignment with the national framework for the advancement of proton therapy, facilitated by the National Cancer Center, HKSH Medical Group (“HKSH”) and Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen (“Shenzhen Cancer Hospital”) signed a memorandum of understanding (“MOU”) on 11 December 2025. The MOU was signed by Dr. Walton LI,... -
2025-12-17
(17 December 2025, Hong Kong) With an ageing population, dementia, which is closely linked to age, is becoming increasingly common in Hong Kong. Data show1 that the prevalence rate is 1.1% for people aged 60-64, soaring to 49.8% by age 85. Alzheimer's disease is the most common form of dementia. However, according to the World Health Organization, it remains underdiagnosed and... -
2025-11-13
(13 November 2025, Hong Kong) Hosted by The Li Shu Fan Medical Foundation and HKSH Medical Group (HKSH), and organised by the Asia-Oceania Particle Therapy Co-operative Group (PTCOG-AO), the 5th Annual Conference of the Asia-Oceania Particle Therapy Co-operative Group (PTCOG-AO 2025 Conference) was successfully held from 7 to 9 November 2025. Marking the first-ever landmark... -
2025-10-30
(30 October 2025, Hong Kong) HKSH Medical Group (HKSH), having installed Asia’s first PhotonCounting Computed Tomography Simulator (PCCT-Sim) in August 2025, signed a Memorandum of Understanding (MOU) with Siemens Healthineers, the world’s first innovator of photon-counting technology, at a ceremony held on 21 October 2025. This collaboration represents a shared vision to...
